We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current SONN market cap is 5.71M. The company's latest EPS is USD -6.1355 and P/E is -0.30.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 37k | 37k | 37k | 37k | 19k |
| Operating Income | -5.61M | -5.66M | -3.92M | -3.6M | -1.28M |
| Net Income | -5.54M | -5.67M | -3.95M | -3.68M | -1.17M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 30.14M | 0 | 484k | 350k | 148k |
| Operating Income | -8.57M | -24.24M | -25.09M | -29.67M | -18.79M |
| Net Income | -17.84M | -65.6M | -24.98M | -29.72M | -18.83M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.94M | 13.31M | 10.04M | 5.43M | 5.34M |
| Total Liabilities | 8.48M | 7.94M | 6.62M | 5.66M | 2.77M |
| Total Equity | -3.54M | 5.37M | 3.42M | -226k | 2.57M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 31.53M | 7.99M | 28.99M | 5.83M | 5.43M |
| Total Liabilities | 34.69M | 4.97M | 6.73M | 8.37M | 5.66M |
| Total Equity | -3.15M | 3.02M | 22.26M | -2.54M | -226k |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.92M | -10.61M | -16.78M | -21.34M | -3.09M |
| Investing | N/A | -261k | -273k | -443k | N/A |
| Financing | 4.56M | 19.21M | 21.02M | 21.01M | 3.84M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.05M | -15.62M | -22.55M | -27.69M | -21.34M |
| Investing | 679k | -76k | -4k | -896k | -443k |
| Financing | 3.34M | 23.01M | 42.83M | 4.01M | 21.01M |
| Market Cap | 5.71M |
| Price to Earnings Ratio | -0.30 |
| Price to Sales Ratio | 38.59 |
| Price to Cash Ratio | 2.51 |
| Price to Book Ratio | -25.26 |
| Dividend Yield | - |
| Shares Outstanding | 3.07M |
| Average Volume (1 week) | 12.8k |
| Average Volume (1 Month) | 17.89k |
| 52 Week Change | -64.02% |
| 52 Week High | 26.40 |
| 52 Week Low | 1.08 |
| Spread (Intraday) | 0.24 (12.24%) |
| Company Name | Sonnet BioTherapeutics Holdings Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.sonnetbio.com |
| Industry | management consulting svcs (8742) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
